PerkinElmer Enhances Mass Spectrometry Product Range and Expertise

The acquisition is an integral part of PerkinElmer's commitment to enlarge its human and environmental health portfolio. With the completion of this acquisition, PerkinElmer will gain significant insight and intellectual property in the field of MS and ion source technology. Terms of the acquisition were not disclosed.

For human health applications, mass spectrometry provides an extremely detailed profile of medically relevant materials in molecular diagnostics and drug discovery. Other areas of applications include pharmaceutical and nutraceutical materials analysis, forensics, and food safety.

PerkinElmer will integrate Analytica's current manufacturing operations into its Shelton, CT (USA) facility, while utilizing Analytica's existing Branford facility for R&D projects. Craig Whitehouse will become an employee of PerkinElmer and oversee PerkinElmer's MS R&D operations.

"Mass spectrometry has proven to be an essential tool in many fields and will continue to be of critical importance. Bringing Analytica's technology and team of highly innovative experts in-house will dramatically increase our capabilities in this area," said Richard Begley, Ph.D., president, analytical sciences, PerkinElmer.

Related Links:
PerkinElmer